Drug Therapy in Epilepsy

Slideshow

Drug therapy is the mainstay of seizure treatment. We present recent findings in anti-epileptic drug research.

Drug therapy is the mainstay of seizure treatment. A combination of two anti-epileptic drugs, ezogabine and retigabine, has proven to be an effective adjunctive therapy in adults in partial-onset seizure. Another drug, Fycompa, has received an expanded indication as an adjunctive treatment of primary generalized tonic-clonic seizures in patients 12 years of age and older with epilepsy. However, the anti-epileptic eslicarbazepine leads to a high frequency of hyponatremia and its use needs to be monitored, especially in elderly post-stroke patients.

Related Videos
Claude Steriade, MD, CM
Fred Lado, MD, PhD
Patricia C. Dugan, MD
Iryna Leunikava, MSc
Derek Ems, MPH, CPHQ
Jude Luker, BA (Hons), head of Patient Engagement, Epilepsy and Rare Syndromes (Europe) at UCB Pharma
Claude Steriade, MD, CM
Jude Luker, BA (Hons), head of Patient Engagement, Epilepsy and Rare Syndromes (Europe) at UCB Pharma
© 2024 MJH Life Sciences

All rights reserved.